Knowing what's out there: Awareness of non-alcoholic fatty liver disease

Frontiers in Medicine

Volumn 1, Issue MAR, 2014, Pages

  Ghevariya, Vishal ^a   Sandar, Nan ^a   Patel, Kishor ^b   Ghevariya, Nehal ^b   Shah, Ruchit ^a   Aron, Joshua ^a   Anand, Sury ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Cirrhosis; Fatty liver; Liver cancer; Non alcoholic fatty liver disease; Steatohepatitis; Steatosis

Indexed keywords

EID: 85041785170     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2014.00004     Document Type: Article

References (22)

1. Tsai CH, Li TC, Lin CC. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med J (2008) 101:900-5. doi:10.1097/SMJ.0b013e31817e8af9
2. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histological spectrum of non alcoholic fatty liver disease associated with normal ALT values. Hepatology (2003) 37:1286-92. doi:10.1053/jhep.2003.50229
3. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med (2000) 132:112-7. doi:10.7326/0003-4819-132-2-200001180-00004
4. Nomura H, Kshiwagi S, Hayashi J, Kajiyama W, Tami S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med (1988) 27:142-9. doi:10.2169/internalmedicine1962.27.142
5. Luyckx FH, Desaive C, Thiry A, Dewé W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord (1998) 22:222-6. doi:10.1038/sj.ijo.0800571
6. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci (1995) 40:2002-9. doi:10.1007/BF02208670
7. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children: ultrasonographic and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci (1997) 42:1428-32. doi:10.1023/A:1018850223495
8. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994. Am J Epidemiol (2013) 178(1):38-45. doi:10.1093/aje/kws448
9. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord (1998) 22:39-47. doi:10.1038/sj.ijo.0800541
10. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol (1990) 85:1349-55
11. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the third national health and nutrition examination survey, 1988-1994. Diabetes Care (1998) 21:518-24. doi:10.2337/diacare.21.4.518
12. Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus. Prog Liver Dis (1970) 3:371-407
13. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ (2011) 343:d6891. doi:10.1136/bmj.d6891
14. American Gastroenterological Association. American gastroenterological association medical position statement: nonalcoholic fatty liver disease. Gastroenterology (2002) 123:1702-4. doi:10.1053/gast.2002.36569
15. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol (2008) 103:2263-71. doi:10.1111/j.1572-0241.2008.02034.x
16. Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology (2006) 43:1145-51. doi:10.1002/hep.21171
17. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol (2008) 49:600-7. doi:10.1016/j.jhep.2008.06.012
18. Raszeia-Wyszomirska J, Lawniczak M, Marlicz W, Miezynska-kurtycz J, Milkiewicz P. Non-alcoholic fatty liver disease-new view. Pol Merkur Lekarski (2008) 24:568-71
19. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med (2005) 353:2111-20. doi:10.1056/NEJMoa050156
20. Bouzianas DG, Bouziana SD, Hatsitolios AL. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutr Rev (2013) 71(11):753-71. doi:10.1111/nure.12073
21. Ong JP, Ptts A, Younoussi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol (2008) 49:608-12. doi:10.1016/j.jhep.2008.06.018
22. Said A, Gagovic V, Malecki K, Givens ML, Nieto FJ. Primary care practitioners' survey of non-alcoholic fatty liver disease. Ann Hepatol (2013) 12:758